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Chapter 5  
Rapid biofunctionalization of magnetic beads with 
function-spacer-lipid constructs
KODE™ Technology is based on novel water-disper-
sible self-assembling molecules, called a function-
spacer-lipids or KODE™ constructs (Figure 1) that 
are able to coat virtually any biological or non-biolo-
gical surface with almost any biological or non-bio-
logical material [1-10]. The primary coating method 
of live cells, organisms, bacteria and viruses or solid 
surfaces (glass, metals, plastics, etc.) is achieved 
by simple contact with a solution containing one or 
more FSL KODE™ constructs. Upon contact the 
FSLs spontaneously and harmlessly create a stable 
and novel surface coating. Essentially the sponta-
neous self-assembling process is driven by the need 
of the constructs to “exclude water”. Because the 
constructs are able to bind to virtually any surface, 
be it hydrophobic or hydrophilic the mechanisms of 
action are multiple and complex and include hydro-
phobic interactions (via lipid tail), hydrophilic interac-
tions (via the head group and spacer), micelle entra-
pment, encapsulation, bi/multi layer assembly, and 
other factors such as hydrogen bonding, van der 
Waals forces, electrostatic and ionic interactions and 
combinations of all the above on complex surfaces.
 
To-date a large range of peptides, simple and com-
plex carbohydrates (including sialic acids and hya-
luronin), peptides, fluorescent markers, reactive 
functional groups, biotin (Figure 1), oligonucleotides, 
radiolabels, chelators, and other functional moieties 
have been created as FSL constructs [1-10]. The 
key advantages of KODE™ Technology over other 
conjugation techniques are that it allows the user to 
create bespoke novel surfaces on demand, and it 
can also harmlessly modify live cells to facilitate their 
attachment to beads. Because multiple different FSL 
constructs can be added simultaneously to a bead, 
and in a controlled manner (by simply altering rela-
tive concentrations of FSLs in the mix), users can 
build on the surface of the bead a variety of complex 
multi-ligand biofunctional surfaces. Furthermore, the 
technology is compatible with existing functionalized 
beads and would allow users to add further featu-
res, such as fluorescent labels, or other enhancing 
or blocking components.
Methodology
The use of FSL constructs with magnetic beads has 
multiple different approaches. The primary approach 
is to simply modify the magnetic bead with a FSL 
construct such as biotin or an antigen to facilitate 
direct binding. This approach can be modified by use 
of a secondarily active component such as strepta-
vidin or an antibody. A further approach is to also 
modify the cell/virus with FSLs to facilitate their atta-
chment to the magnetic beads. These approaches 
to capture live cells or other biological material onto 
magnetic beads are described below.
Preparation of biotin koded  
microspheres
Wash 1g of magnetic microspheres (e.g. Millipore 
Estapor® Magnetic microspheres) with water and 
remove most of the supernatant. Add 2 mL of FSL-
biotin (187786-1-R&D) diluted to 100 µg/mL (50µM) 
in PBS and vortex briefly. Incubate at RT for 1 hour 
and wash once with storage buffer (PBS containing 
Figure 1. Schematic of FSL-biotin. Upper image show one 
possible conformation of the FSL-biotin construct while 
the lower image shows its schematic formula. The spacer 
of FSL biotin is a partially carboxymethylated oligoglycine 
while the lipid tail is 1,2-dioleoyl-sn-glycero-3-phospho 
ethanolamine (DOPE).
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0.1% Tween® 20, 0.5% BSA, 0.05% sodium azide) 
and then store in buffer at 4°C for up to 1 year. These 
biotin microspheres can be use to capture avidinyla-
ted biological or non-biological material.
Preparation of streptavidin koded  
microspheres
Decant supernatant from biotin koded microspheres 
and add a solution of streptavidin (1 mg/mL) in a ra-
tio of 2 mL per gram of microspheres. Vortex briefly 
and incubate at RT for 1 hour, with mixing after 30 
minutes. Wash twice in storage buffer, then store 
in buffer at 4°C for up to 1 year. Note: Streptavidin 
and neutravidin coatings perform better than avidin. 
These biotin-avidinylated microspheres can be use 
to capture biotinylated biological or non-biological 
material.
Capturing biotin kodecytes onto  
streptavidin koded microspheres
Prepare kodecytes by contacting cells (red cells, 
culture lines, sperm, embryo, bacteria, etc) with a 
50 µM solution of FSL-biotin, or FSS-biotin (416662-
1-R&D) for 1 hour at 37°C. Capture the biotin ko-
decytes onto streptavidin koded microspheres by 
simply bringing them into contact (Figure 2). The 
attachment is sufficiently robust to magnetically iso-
late the kodecytes captured on the koded magnetic 
microspheres from other cells in a mixture.
Capturing cells onto antibody koded 
microspheres
Preparing antibody koded microspheres is essentia-
lly the same method as preparing streptavidin koded 
microspheres except the FSL-biotin is exchanged 
for an FSL–antigen and the streptavidin is replaced 
with a high-titre high-affinity IgM antibody. Capture 
of antigen positive cells requires simple contact with 
the antibody koded microspheres.
Release of captured intact cells from 
koded microspheres
Dilute the recovered cell covered microspheres 
about 10-fold with PBS. Vortex for 1 minute to re-
lease most of the microspheres from the kodecytes/
cells, and immediately magnetically separate the 
beads and decant the released kodecytes/cells. Lar-
ge microspheres are required to obtain the shear-
forces required for full release of all microspheres 
from kodecytes/cells. Released kodecytes/cells will 
be functional, but will contain traces of FSL-cons-
tructs and/or related material on their surfaces. 
These surface preparation remnants should be lost 
within 48 hours on cells with an active membrane.
Summary
In summary within a few hours a magnetic bead (or 
any surface) can be modified with an appropriate 
FSL construct and used to specifically capture live 
cells, virions, particles, or other biological or non-
biological material.
 
FSL-biotin and other research related FSL-constructs 
are available from Sigma-Aldrich and KODE Biotech 
Materials Ltd. Further information on KODE™ Tech-
nology can be found at www.kodecyte.com
Figure 2. Typical results of cells (7 µm red cells) 
being coated with magnetic microspheres (1 µm ) 
biofunctionalized with FSL-constructs. In this example 
the magnetic microspheres are functionalized with FSL-
biotin+streptavidin and the red cells are functionalized 
with FSL-biotin.  Photo (200×) shows cells post magnetic 
isolation, but before being released from the microspheres 
by vortexing.
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